Biomarker

Home
Podcast
Archive
Leaderboard
About
Voyager: Al Sandrock
“All it takes is to meet one patient who has benefited from a drug you helped to develop.”
 • 
Dylan Neel
Novartis: Jennifer Brogdon
"There is no script or playbook for this scenario—but we felt that we were mapping a new landscape in medicine."
 • 
Dylan Neel
Lab Meeting: Maria Grazia Roncarolo
"Tr1 cells have the potential to not only provide symptom relief, but also reset the immune system to provide cures.”
 • 
Dylan Neel
 and 
Tito Adhikary
Radiopharm Renaissance
Case studies, market dynamics and technical hurdles for radioligand therapies
 • 
Dylan Neel
, 
Joseph Mekhael
, and 
Dennis Gong
24 Biotech Investors in 2024
Rising stars in biotech investing and creation discuss how they got started, lessons learned and tips to break into the industry.
 • 
Dylan Neel
 and 
Shreya Mantri
Lab Meeting: Mike Rosenblatt
“The biggest breakthroughs are those that wipe away disease.”
 • 
Dylan Neel
SR One: Simeon George
“You have to feel fired up about what you're doing.”
 • 
Dylan Neel
 and 
Shreya Mantri
1
Biomarker
Biomarker
Interviews with scientists, physicians, industry experts and investors.
Recommendations
Transition States
Transition States
Nick Edwards
BIOS+
BIOS+
BIOS
© 2024 Dylan Neel
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture